InvestorsHub Logo
Followers 52
Posts 9069
Boards Moderated 1
Alias Born 10/25/2007

Re: None

Thursday, 03/14/2024 12:27:22 AM

Thursday, March 14, 2024 12:27:22 AM

Post# of 13430
There's a big need for RSV vaccines. Even with two rivals already on the market, mRNA-1345 should be quite competitive, with its solid efficacy and prefilled syringe, which makes it easier for pharmacists and doctors.

Moderna also plans to file for FDA approval of its seasonal flu vaccine mRNA-1010 in 2024
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News